Literature DB >> 33403148

Primary pulmonary meningioma mimicking pulmonary metastasis: A rare case report.

Nesrin Gürçay1, Ayperi Öztürk2, Funda Demirağ1, Funda İncekara3.   

Abstract

Primary pulmonary meningiomas are rare and mostly benign tumors. They usually appear as a solid peripheral pulmonary nodule on chest radiography and computed tomography and are frequently diagnosed incidentally. Herein, we report a 55-year-old female case of primary pulmonary meningioma mimicking pulmonary metastasis.
Copyright © 2020, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Metastasis; primary pulmonary meningioma; solitary pulmonary nodule

Year:  2020        PMID: 33403148      PMCID: PMC7759054          DOI: 10.5606/tgkdc.dergisi.2020.19370

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


Introduction

Meningiomas are the most common intracranial tumors, which occur rarely in the lungs as a primary or metastatic lesion. In the lung, the incidence of metastatic meningiomas is very low and primary pulmonary meningioma (PPM) is even rarer. Since the first case was reported by Kemnitz et al.[1] in 1982, approximately 60 cases of PPM have been reported in the English medical literature.[1] APPM is usually benign and often appears as a solid pulmonary nodule on chest radiography and computed tomography (CT), which is incidentally detected in the majority of cases.[2] In this report, we present a case of PPM mimicking pulmonary metastasis based on the previous history of a leiomyoma.

Case Report

A 55-year-old female patient was admitted with persistent cough for more than two weeks. Her medical history revealed a history of hysterectomy for a uterine leiomyoma 10 years ago and existing asthma for seven years. Physical examination and laboratory test results were normal. A 2×2-cm solitary, peripheral ground-glass nodule was detected in the posterior segment of the right upper lobe of the lung on chest radiography and CT scan (Figure 1). The nodule had a low metabolic activity (maximum standardized uptake value [SUVmax]:1.89) on fluorodeoxyglucose positron-emission tomography (FDG-PET). Fiberoptic bronchoscopy revealed no pathological findings. As a result, thoracoscopic wedge resection of the right upper lobe was decided. A written informed consent was obtained from the patient.
Figure 1

(a) Chest radiography showing nodular opacity in right upper lobe, (b, c) A 2×2-cm solitary ground-glass nodule located in posterior segment of right upper lobe on computed tomography.

The patient underwent thoracoscopic wedge resection of the right upper lobe. The wedge resection material was 5×5×3 cm in size and a 2×2×1.8-cm, well-demarcated solitary peripheral nodule was detected. The cut surface of the tumor was yellowishwhite in color. Based on the patient"s history and radiological findings, a primary tumor or benign metastatic leiomyoma was initially suspected. On microscopic examination, however, we observed a large amount of psammoma bodies and a lesion with whorl formation consisting of spindleshaped cells and meningothelial cellular nests without nuclear atypia and mitosis in hematoxylin-eosin (H-E) sections (Figure 2). Immunohistochemical (IHC) analyses demonstrated focal cytoplasmic staining of the epithelial membrane antigen (EMA), strong cytoplasmic staining of S100 protein and Vimentin protein, and nuclear staining of progesterone receptors (PR) on tumor cells. Contrarily, there were no expression for desmin, smooth muscle actin (SMA), and pancytokeratin (panCK) on tumor cells. Based on histomorphological and immunohistochemical features, the patient was diagnosed with a transitional (mixed) type of benign meningioma.
Figure 2

(a) A peripheral pulmonary nodule, H-E ×40. (b) Tumor consists of spindle-shaped cells and meningothelial cellular nests with whorl formation and psammoma bodies, H-E ×200. (c) IHC staining of EMA focal positivity, ×200. H-E: Hematoxylin-eosin; IHC: Immunohistochemical; EMA: Epithelial membrane antigen.

Postoperative intracranial and spinal magnetic resonance imaging revealed no mass at two months after surgery. Therefore, the patient was diagnosed with PPM. The patient is still free from recurrence two years after surgery.

Discussion

Meningiomas are the most common benign brain tumors originating from meningothelial cells of the arachnoid surface.[3] The incidence of primary extracranial meningioma is very rare (2%) and can be located in various anatomical sites such as the scalp, nasal sinuses, soft tissue, lungs, parotid gland, adrenal gland, skin, and peripheral nerves.[4] Although its etiology is still unclear, minute pulmonary meningothelial-like nodules, pluripotential cells, heterotrophic embryonic rests, and possible ectopic neuroectodermal tissues in the lung are the most widely adopted theories in the etiology of PPM.[5] In addition, PPM and meningothelial-like nodules show similar histomorphological and immunohistochemical properties; however, genotype characteristics may be different.[2,4] Furthermore, controversial results were reported regarding the incidences of meningioma and meningothelial-like nodules in autopsy series (0.5% vs. 0.05%, respectively). Primary pulmonary meningiomas are more common in adults with a slight female predominance. These tumors may affect all age groups ranging from 18 to 108 years.[6] Although the majority of patients are asymptomatic, some patients may present with chest pain, hemoptysis, cough, or shortness of breath. The tumor size varies from 0.4 to 6 cm in diameter. Lesions have a high FDG uptake, compatible with malignancy on PET.[5] According to the 2015 World Health Organization classification of the tumors of the lung, PPMs are classified in tumors of ectopic origin.[6] On gross examination, most pulmonary meningiomas have a yellow-tan and homogeneous cut surface. Their cytological and histological findings are also similar to meningiomas of the central nervous system.[6,7] The presence of psammoma bodies, absence of mitotic activity, and focal areas of foamy macrophages are other histological features of PPMs in benign nature.[7] An increased mitotic activity, necrosis, nuclear atypia, and intranuclear inclusions are present in cases of malignant meningiomas. Tumor cells typically express Vimentin and EMA, occasionally and focally express S100 and PR, while cytokeratin, CD34, and neuroendocrine markers are negative. An increased Ki67 proliferation index can be seen in malignant meningiomas. The prognosis of PPM is usually excellent. The surgical approaches are lobectomy or segmentectomy for central lesions and wedge resection for small peripheral nodules. No recurrences or metastasis has been reported in the long-term follow-up of benign cases. However, malignant PPMs may have an aggressive clinical behavior and cause recurrence.[6,7] In the preoperative differential diagnosis of PPMs, sclerosing hemangioma, hyalinizing granuloma, intrapulmonary fibrous tumor, and inflammatory pseudotumor should be considered.[8] According to microscopic examination, spindle cell thymoma, solitary fibrous tumor, well-differentiated neuroendocrine tumor (carcinoid), malignant meningioma, meningothelial-like nodule, meningotheliomatosis, and monophasic synovial sarcoma are the diseases which should be considered in the histopathological differential diagnosis of PPMs.[6] In conclusion, primary pulmonary meningioma is a rare disease and is usually benign in nature. It should be considered in the differential diagnosis of single or multiple pulmonary nodules. A careful pathological, clinical, and radiological examination are required for the definitive diagnosis of primary pulmonary meningioma.
  8 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Primary pulmonary meningioma: report of a case and review of the literature.

Authors:  Matteo Incarbone; Giovanni Luca Ceresoli; Luca Di Tommaso; Federico Cappuzzo; Francesco Inzirillo; Maurizio Infante; Marco Alloisio
Journal:  Lung Cancer       Date:  2008-05-19       Impact factor: 5.705

3.  Primary pulmonary meningioma.

Authors:  Pradeep Vaideeswar; Jayashri Chaudhari
Journal:  Indian J Pathol Microbiol       Date:  2019 Jul-Sep       Impact factor: 0.740

4.  Fine needle aspiration cytology of primary pulmonary meningioma associated with minute meningotheliallike nodules. Report of a case with histologic, immunohistochemical and ultrastructural studies.

Authors:  Virginia Gomez-Aracil; Emilio Mayayo; Rosa Alvira; Alfonso Arraiza; Santiago Ramón y Cajal
Journal:  Acta Cytol       Date:  2002 Sep-Oct       Impact factor: 2.319

5.  Primary pulmonary meningioma: an unusual cause of a nodule with strong and homogeneous enhancement.

Authors:  Yeun Yoon Kim; Yong Kook Hong; Jeong-Hae Kie; Seok Jong Ryu
Journal:  Clin Imaging       Date:  2015-08-07       Impact factor: 1.605

6.  Primary Pulmonary Meningioma Simulating a Pulmonary Metastasis.

Authors:  Chun-Mao Juan; Mei-Ling Chen; Shang-Yun Ho; Yuan-Chun Huang
Journal:  Case Rep Pulmonol       Date:  2016-11-16

7.  A case report of resected ectopic malignant meningioma with lung metastasis.

Authors:  Kotaro Murakami; Hidenobu Takahashi; Tomokazu Omori; Osamu Uchida; Hiroshi Hirano; Norihiko Kawate; Norihiko Ikeda
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Primary pulmonary meningioma mimicking lung metastatic tumor: a case report.

Authors:  Ji-Zhuang Luo; Cheng Zhan; Xiang Ni; Yu Shi; Qun Wang
Journal:  J Cardiothorac Surg       Date:  2018-10-01       Impact factor: 1.637

  8 in total
  2 in total

1.  Primary pulmonary meningioma: A case report and review of the literature.

Authors:  Dan-Bin Zhang; Tao Chen
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 2.  Multiple primary pulmonary meningioma: A case report and literature review.

Authors:  Xin Huang; Yun-Fei Mou; Fu-Qiang Ren; Yuan Wang; Yi Yang
Journal:  Thorac Cancer       Date:  2022-06-22       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.